newsfilter
← Latest News
FDA Approved Drugs·

Approval of Adzenys Xr-odt, Nda #204326 (Labeling)

Approval Date: 09/23/2025; Drug Name: Adzenys Xr-odt, Nda #204326; Active Ingredients: AMPHETAMINE; Company: Neos Theraps; Submission Status: Approval; Submission Classification: Labeling; Application Number: 204326

Company
NEOS THERAPS
Keywords
NEOS THERAPS